Canadian Institute’s Pathways To Access & Reimbursement

Join the conversation about a changing pharma landscape at the Pathways to Access & Reimbursement Forum on June 9-10, 2020 in Toronto.

Top Reasons to Attend:

Get direction on the latest changes to drug reviews and pricing ceilings to better inform market access and pricing strategies
Gain insights on reimbursement regimes though Q & A with public and private payers
Walk away with an understanding of how to bring innovative solutions to market
Hear how other jurisdictions are approaching HTA and pricing negotiations
Learn about developments in precision medicine that could increase the safety and efficacy of treatments while reducing healthcare spending